3G·

Medpace Holdings reports Q1 2025

Medpace Holdings ($MEDP (+3,59%) ) reports Q1 2025 earnings:

Q1 2025:

Sales: 558.6M vs. 527M expected (+6%) 🟢

EBITDA: 118.6M vs. 118M expected (+0.5%) 🟡

EBIT: 113.5M vs. 109M expected (+4.1%) 🟢

Net Income: 114.6M vs. 96M expected (+19.3%) 🚀

Outlook for FY2025:

Sales: 2190M vs. 2149M expected (+1.9%) 🟡

EBITDA: 477M vs. 477M expected (+0%) 🟡

Net Income: 390.0M vs. 387M expected (+0.7%) 🟡

eine Milliarde Aktienrückkaufprogramm angekündigt. Book-to-Bill fällt allerdings weiter auf 0.9 (von 0.99)

5 Commenti

Soprano@Soprano

1 billion share buyback is gigantic - that's more than 10% of the shares

•

SemiGrowth@SemiGrowth

@Soprano They did the same thing in 2022. The outstanding shares fell from 35K to 31K

•

Tenbagger2024@Tenbagger2024

But it has also come under a lot of pressure.

•

Finanzielle-Freiheit@Finanzielle-Freiheit

Presumably because of the book-to-bill ratio because otherwise these figures are very strong in my opinion for what was forecast for 2025 at the end of 2024 - how do you currently rate Medpace?

••

SemiGrowth@SemiGrowth

@Finanzielle-Freiheit Of course it's the book to bill. Medp mainly serves (80%) small companies, which are more dependent on the economy

•